At present, there are no approved antiviral drugs for Nipah and supportive care is the only option for human infections.

Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...

Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 ...

New imaging tools reveal how within an hour of infection, the virus begins to alter our chromosomes to kick-start its own replication.

"These viruses are so closely related to MERS, so we have to be concerned if they ever infect humans," said virologist Michael Letko.

Viruses take advantage of proteins or receptors on the surfaces of human cells to gain entry into those cells, and start an infection. Human cells have receptors that can interact with viral proteins, ...

A new study reveals the biological secret to the Zika virus's infectious success: Zika uses host cells' own "self-care" system of clearing away useless molecules to suppress the host proteins that ...

Using a novel microscopy technique, researchers revealed how influenza viruses interact with host cells. The method enabled real-time visualization of viral contact and identified a new receptor used ...

Bacteriophages, or phages, viruses that selectively target and infect bacteria, have drawn growing attention for their potential use in a host of biotechnological processes to benefit humankind, from ...

Hemagglutinin—the “H” in “H5N1”—is a protein that helps influenza viruses bind to host cells; the hemagglutinin achieves this by recognizing receptors that line those cells. The ...

A new study finds tweaking part of the H5N1 virus infecting dairy cows in a single spot could allow it to better attach to human cell receptors, raising concerns it could transmit more easily ...